Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000128264 | SCV000171856 | benign | not specified | 2013-03-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000128264 | SCV000342660 | likely benign | not specified | 2016-07-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000462041 | SCV000562992 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2025-01-25 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000128264 | SCV000615447 | benign | not specified | 2016-10-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312944 | SCV000847784 | likely benign | Inborn genetic diseases | 2016-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001808380 | SCV002056693 | benign | Developmental and epileptic encephalopathy, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001808380 | SCV002813175 | likely benign | Developmental and epileptic encephalopathy, 5 | 2021-08-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003311692 | SCV004010868 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | SPTAN1: BP4, BP7 |